Enhanc3D in a $7.7M series A extension with Business Growth Fund, Parkwalk Advisors and Bioqube Ventures
18 September 2025
18 September 2025
Total investments received (USD): 18.98M
Round value (USD): 7.7M
Company: Enhanc3D
Related deals
Oxford Medical Simulation in a £5 million growth funding from Salica Investments
Investments
01 March 2026
Entourage AI in a £3.8M pre-seed raise led by Provision, joined by GU Holdings and angel investors.
Investments
01 March 2026
Brainomix in a £4.8 million Series C extension co-led by Parkwalk and Hostplus, joined by Modi Ventures.
Investments
13 February 2026
Antiverse in a $9.3 million Series A round led by Soulmates Ventures, joined by Innovation Investment Capital, DOMiNO Ventures, Kadmos Capital and i&i
Investments
11 February 2026
Centauri Therapeutics secured a £6 million series A extension investment from the AMR Action Fund,
Investments
08 February 2026
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain